Publications by authors named "Ana Maria Isac"

Claim this Profile
N
Novel PROTACs targeting tissue transglutaminase (TG2) suppress tumorigenicity of ovarian cancer cells.
Andres Valdivia, Joshua L Zhu, Vanessa Hernandez, Purav P Vagadia, Natalia Masnica, Ana Maria Isac

Eur J Med Chem· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Dependency on De Novo Pyrimidine Synthesis is a Targetable Vulnerability in Platinum Resistant Ovarian Cancer.
Horacio Cardenas, Yinu Wang, Guangyuan Zhao, Delan Xingyue Hao, Ana Maria Isac

Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mid-Infrared Photothermal Imaging of Fatty Acid Desaturation Reaction in Cancer Cells.
Xinyan Teng, Tianyu Xia, Jiaze Yin, Mingsheng Li, Jianpeng Ao, Ana Maria Isac

bioRxiv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement activation at the interface between adipocytes and cancer cells drives tumor progression.
Andres Valdivia, Ana Maria Isac, Horacio Cardenas, Guangyuan Zhao, Yaqi Zhang

JCI Insight· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E2F1 mediates competition, proliferation and response to cisplatin in cohabitating resistant and sensitive ovarian cancer cells.
Andres Valdivia, Matthew Cowan, Horacio Cardenas, Ana Maria Isac, Guangyuan Zhao

Front Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis